PubMed Health treatment related to Heart Valve Disease: 63
Currently, no medicines can cure heart valve disease . However, lifestyle changes and medicines often can successfully treat symptoms and delay problems for many years. Eventually, though, you may need surgery to repair or replace a faulty heart valve. The goals of treating heart valve disease might include: Preventing, treating, or relieving the symptoms of other related heart conditions. Protecting heart valves from further damage. Repairing or replacing faulty valves when they cause severe symptoms or become life threatening. Replacement valves can be man-made or biological.
Drugs for Heart Valve Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 238)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Acetylcysteine |
Approved, Investigational |
Phase 4 |
|
616-91-1 |
581 12035 |
Synonyms:
(2R)-2-ACETAMIDO-3-SULFANYLPROPANOIC ACID
(2R)-2-Acetylamino-3-sulfanylpropanoate
(2R)-2-Acetylamino-3-sulfanylpropanoic acid
(2R)-2-Acetylamino-3-sulphanylpropanoate
(2R)-2-Acetylamino-3-sulphanylpropanoic acid
(R)-2-Acetylamino-3-mercaptopropanoate
(R)-2-Acetylamino-3-mercaptopropanoic acid
(R)-Mercaptate
(R)-Mercaptic acid
(R)-Mercapturic acid
2-[(1-Hydroxyethylidene)amino]-3-sulfanylpropanoate
2-[(1-Hydroxyethylidene)amino]-3-sulphanylpropanoate
2-[(1-Hydroxyethylidene)amino]-3-sulphanylpropanoic acid
2-acetylamino-3-mercapto-Propionate
2-acetylamino-3-mercapto-Propionic acid
5052
Ac pharma brand OF acetylcysteine
ACC
ACC-600
Acebraus
Acemuc
Acetabs
Acetadote
Acetilcisteina
Acetylcystein al
Acetylcystein atid
Acetylcystein heumann
Acetylcystein trom
Acetylcystein, mentopin
Acetylcysteine
Acetylcysteine ac-pharma brand
Acetylcysteine alcon brand
Acetylcysteine aluid brand
Acetylcysteine atid brand
Acetylcysteine azupharma brand
Acetylcysteine betapharm brand
Acetylcysteine bioiberica brand
Acetylcysteine bouchara brand
Acetylcysteine centrafarm brand
Acetylcysteine disphar brand
Acetylcysteine farmasan brand
Acetylcysteine fresenius brand
Acetylcysteine génévrier brand
Acétylcystéine GNR
Acetylcysteine GNR-pharma brand
Acetylcysteine guerbet brand
Acetylcysteine hermes brand
Acetylcysteine heumann brand
Acetylcysteine hydrochloride
Acetylcysteine inpharzam brand
Acetylcysteine intra brand
Acetylcysteine klinge brand
Acetylcysteine krewel brand
Acetylcysteine lichtenstein brand
Acetylcysteine lindopharm brand
Acetylcysteine merck brand
Acetylcysteine oberlin brand
Acetylcysteine pfleger brand
Acetylcysteine pharbita brand
Acetylcysteine roberts brand
Acetylcysteine sodium
Acetylcysteine temmler brand
Acetylcysteine teva brand
Acetylcysteine thiemann brand
Acetylcysteine trommsdorff brand
Acetylcysteine upsa brand
Acetylcysteine whitehall brand
Acetylcysteine zambon brand
Acetylcysteine zinc
Acetylcysteine zyma brand
Acetylcysteine, (D)-isomer
Acetylcysteine, (DL)-isomer
Acetylcysteine, monoammonium salt
Acetylcysteine, monosodium salt
Acetylcysteinum
Acetylin
Acetyst
Acid, mercapturic
Ac-pharma brand OF acetylcysteine
A-CYS
Airbron
Alcon brand OF acetylcysteine
Allen and hanburys brand OF acetylcysteine
Aluid brand OF acetylcysteine
Alveolex
Atid brand OF acetylcysteine
Azubronchin
Azupharma brand OF acetylcysteine
Betapharm brand OF acetylcysteine
Bioiberica brand OF acetylcysteine
Bisolvon nac
Boehringer ingelheim brand OF acetylcysteine
Bouchara brand OF acetylcysteine
Bristol myers squibb brand OF acetylcysteine
Bristol myers squibb brand OF acetylcysteine sodium salt
Bristol-myers squibb brand OF acetylcysteine
Bristol-myers squibb brand OF acetylcysteine sodium salt
Bromuc
broncho Fips
broncho-Fips
BronchoFips
Broncholysin
Broncoclar
Centrafarm brand OF acetylcysteine
CETYLEV
Codotussyl
Cystamucil
dampo Mucopect
|
Dey brand OF acetylcysteine sodium salt
Disphar brand OF acetylcysteine
Durabronchal
EN-CYS
Eurespiran
Exomuc
Fabrol
Farmasan brand OF acetylcysteine
Fluimicil infantil
Fluimucetin
Fluimucil
FLUIMUCIL 600
FLUIMUCIL LONG
FLUIMUCIL N
Flumucetin
Fluprowit
Frekatuss
Fresenius brand OF acetylcysteine
Genac
Génévrier brand OF acetylcysteine
GNR Pharma brand OF acetylcysteine
GNR-Pharma brand OF acetylcysteine
Guerbet brand OF acetylcysteine
Hermes brand OF acetylcysteine
Heumann brand OF acetylcysteine
Hoestil
Hustengetränk, optipect
Hydrochloride, acetylcysteine
Ilube
Inpharzam brand OF acetylcysteine
Intra brand OF acetylcysteine
Jenacystein
Jenapharm
Klinge brand OF acetylcysteine
Krewel brand OF acetylcysteine
L-a-Acetamido-b-mercaptopropionate
L-a-Acetamido-b-mercaptopropionic acid
L-Acetylcysteine
L-alpha-Acetamido-beta-mercaptopropionate
L-alpha-Acetamido-beta-mercaptopropionic acid
Lantamed
Larylin nac
Lichtenstein brand OF acetylcysteine
Lindocetyl
Lindopharm brand OF acetylcysteine
Lysox
L-Α-acetamido-β-mercaptopropionate
L-Α-acetamido-β-mercaptopropionic acid
m Pectil
Mentopin acetylcystein
Mercaptate
Mercaptic acid
Mercapturic acid
Merck brand OF acetylcysteine
Monoammonium salt acetylcysteine
Monosodium salt acetylcysteine
m-Pectil
MPectil
Muciteran
muco Sanigen
Mucolysin
Mucomyst
Mucopect, dampo
Mucosil
MUCOSIL-10
MUCOSIL-20
Mucosol
Mucosolvin
N Acetyl L cysteine
N Acetylcysteine
NAC
NAC al
NAC zambon
NAC, bisolvon
N-Acetyl-3-mercaptoalanine
N-Acetylcysteine
N-Acety-L-cysteine
N-Acetyl-L-(+)-cysteine
N-Acetyl-L-cysteine
NSC-111180
Oberlin brand OF acetylcysteine
Optipect hustengetränk
ORONAC 600
PARVOLEX
Pfleger brand OF acetylcysteine
Pharbita brand OF acetylcysteine
Produpharm lappe brand OF acetylcysteine
RESPI-NAC
Roberts brand OF acetylcysteine
Roche nicholas brand OF acetylcysteine
Sanigen, muco
Siccoral
Siran
Sodium 2-acetamido-3-mercaptopropionate
Sodium, acetylcysteine
Solmucol
Temmler brand OF acetylcysteine
Teva brand OF acetylcysteine
Thiemann brand OF acetylcysteine
Trommsdorff brand OF acetylcysteine
UPSA brand OF acetylcysteine
Whitehall brand OF acetylcysteine
YOURNAC
Zambon brand OF acetylcysteine
Zambon, nac
Zinc, acetylcysteine
Zyma brand OF acetylcysteine
|
|
2 |
|
Metoprolol |
Approved, Investigational |
Phase 4 |
|
37350-58-6, 51384-51-1 |
4171 |
Synonyms:
(+/-)-metoprolol
(RS)-Metoprolol
1-(Isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
Beatrolol
Beloc
Beloc duriles
Beloc-duriles
BelocDuriles
Betaloc
Betaloc astra
Betaloc-astra
BetalocAstra
Betalok
CGP-2175
CGP-2175C
CGP-2175C|GP-2175E|H-93/26|Lopressor®|Toprol®
CR-XL, Metoprolol
DL-Metoprolol
GP-2175E
H-93/26
Lopresor
Lopresoretic
LOPRESSIDONE
Lopressor
Lopressor HCT
|
Meijoprolol
Metohexal
METOPROLOL
Metoprolol CR XL
Metoprolol CR-XL
Metoprolol succinate
Metoprolol tartrate
Metoprololum
Metroprolol
Preblok
Prelis
Presolol
Seloken
Selopral
Selo-Zok
Seroken
Spesicor
Spesikor
Succinate, metoprolol
Tartrate, metoprolol
Toprol
Toprol XL
ToprolXL
Toprol-XL
|
|
3 |
|
Sufentanil |
Approved, Investigational |
Phase 4 |
|
56030-54-7 |
41693 |
Synonyms:
Chronogesic
Citrate, sufentanil
Curasan brand OF sufentanil citrate
Curasan, sufentanil
Hameln brand OF sufentanil citrate
IDS-NS-001
Janssen brand OF sufentanil citrate
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide
R-30730
Ratiopharm brand OF sufentanil citrate
Sufenta
Sufenta®|sufentanil citrate|Zalviso®
Sufentanil
Sufentanil citrate
|
Sufentanil curasan
Sufentanil hameln
Sufentanil ratiopharm
Sufentanil-hameln
SufentanilHameln
Sufentanilo
Sufentanil-ratiopharm
SufentanilRatiopharm
Sufentanilum
Sufentanilum [INN-Latin]
Sufentanyl
Sulfentanil
Sulfentanil Citrate
Sulfentanyl
Taylor brand OF sufentanil citrate
|
|
4 |
|
Sodium citrate |
Approved, Investigational |
Phase 4 |
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
5 |
|
Sildenafil |
Approved, Investigational |
Phase 4 |
|
139755-83-2, 171599-83-0 |
5212 135398744 |
Synonyms:
1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine
1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulphonyl)-4-methylpiperazine
1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate
1-{[3-(4,7-DIHYDRO-1-METHYL-7-OXO-3-PROPYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-5-YL)-4-ETHOXYPHENYL]SULFONYL}-4-METHYLPIPERAZINE
5-[2-ETHOXY-5-(4-METHYLPIPERAZIN-1-YLSULFONYL)PHENYL]-1-METHYL-3-PROPYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-7(6H)-ONE
5-[2-ETHOXY-5-(4-METHYL-PIPERAZINE-1-SULFONYL)-PHENYL]-1-METHYL-3-PROPYL-1,6-DIHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-7-ONE
Acetildenafil
Aphrodil
Caverta
Citrate, sildenafil
Desmethyl sildenafil
Desmethylsildenafil
HIP0908
HIP-0908
Homosildenafil
Hydroxyhomosildenafil
Lactate, sildenafil
NCX 911
|
NCX-911
NIPATRA
Nitrate, sildenafil
Revatio
Sildenafil
Sildenafil citrate
Sildenafil lactate
Sildenafil nitrate
Sildenafil Viagra
Sildenafil, desmethyl
Sildenafilo
UK-92480
UK-9248010
UK-92480-10
Viagra
Viagra®
VIZARSIN
|
|
6 |
|
Sevoflurane |
Approved, Vet_approved |
Phase 4 |
|
28523-86-6 |
5206 |
Synonyms:
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
Fluoromethyl hexafluoroisopropyl ether
Fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
HFE-347MMZ1
MR6S4
MR-6S4
Sevofluran
SEVOFLURANE
|
Sevoflurano
Sevoflurano [INN-Spanish]
Sevofluranum
Sevofluranum [INN-Latin]
Sevorane
SOJOURN
Ultane
|
|
7 |
|
Remifentanil |
Approved |
Phase 4 |
|
132875-61-7 |
60815 |
Synonyms:
3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester
GI 87084X
GI-87084B
IDS-NR-005
Remifentanil
|
Remifentanil hydrochloride
Remifentanil monohydrochloride
Remifentanilo
Remifentanyl
Ultiva
|
|
8 |
|
Etomidate |
Approved |
Phase 4 |
|
33125-97-2 |
667484 |
Synonyms:
(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate
(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylic acid
(+)-Ethyl 1-(a-methylbenzyl)imidazole-5-carboxylate
(+)-Ethyl 1-(a-methylbenzyl)imidazole-5-carboxylic acid
(+)-Ethyl 1-(α-methylbenzyl)imidazole-5-carboxylate
(+)-Ethyl 1-(α-methylbenzyl)imidazole-5-carboxylic acid
(+)-Etomidate
(+)-Etomidic acid
(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylate ethyl ester
(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester
(R)-(+)-1-(a-Methylbenzyl)imidazole-5-carboxylate ethyl ester
(R)-(+)-1-(a-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester
(R)-(+)-1-(Α-methylbenzyl)imidazole-5-carboxylate ethyl ester
(R)-(+)-1-(Α-methylbenzyl)imidazole-5-carboxylic acid ethyl ester
(R)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylate ethyl ester
|
(R)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylate ethyl ester
3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
AMIDATE
D-ETOMIDATE
Ethomidate
ETOMIDATE
Etomidato
Etomidatum
Etomidic acid
Hypnomidate
R 16659
R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid
Radenarkon
|
|
9 |
|
Thiopental |
Approved, Vet_approved |
Phase 4 |
|
76-75-5 |
3000715 |
Synonyms:
(+-)-Thiopental
(±)-thiopental
2-Thio-5-ethyl-5-sec-pentylbarbitate
2-Thio-5-ethyl-5-sec-pentylbarbitic acid
2-Thio-5-ethyl-5-sec-pentylbarbituric acid
5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione
Abbott brand OF thiopental sodium
Altana pharma brand OF thiopental sodium
Bomathal
Braun brand OF thiopental sodium
Merial brand OF thiopental sodium
Nesdonal
Nycomed brand OF thiopental sodium
Penthiobarbital
Pentothal
Pentothal sodico
Pentothiobarbital
Pharmtech brand OF thiopental sodium
Pisa brand OF thiopental sodium
|
Rhone merieux brand OF thiopental sodium
Sodipental
Sodium Pentothal®|thiopental sodium|Trapanal®
Thiomebumal
Thionembutal
THIOPENTAL
THIOPENTAL CIII
Thiopental nycomed
Thiopental sodium
Thiopentobarbital
Thiopentobarbitate
Thiopentobarbitic acid
Thiopentobarbitone
Thiopentobarbituric acid
Thiopentone
Tiobarbital braun
Tiopentale
Trapanal
|
|
10 |
|
Hydrocortisone succinate |
Approved |
Phase 4 |
|
2203-97-6 |
3643 |
Synonyms:
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadec-6-en-14-yl}-2-oxoethoxy)-4-oxobutanoate
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-yl}-2-oxoethoxy)-4-oxobutanoate
Cortisol 21-(hydrogen succinate)
Cortisol succinate
HYDROCORTISONE HEMISUCCINATE
|
Hydrocortisone hemisuccinate anhydrous
Hydrocortisone hydrogen succinate
HYDROCORTISONE SUCCINATE
Hydroxycortisone succinate
NSC-7576
|
|
11 |
|
Hydrocortisone acetate |
Approved, Vet_approved |
Phase 4 |
|
50-03-3 |
|
Synonyms:
21-O-acetylcortisol
BARQUINOL HC
CHLOROMYCETIN HYDROCORT
COLIFOAM
CORTEF ACETATE
CORTIFOAM
Cortisol 21-acetate
CORTRIL
CORTUCID
DRICORT
EPIFOAM
FRAMYCORT
FUCIDIN H
GENTICIN HC
GENTISONE HC
|
GPPE EAR SUSP
GPPE EYE CRM
GPPE FOAM AERO
HC45 HYDROCORT
HEMSOL-HC
HEPACORT PLUS
HYDROCAL
HYDROCORTISONE 21-ACETATE
HYDROCORTISONE ACETATE
HYDROCORTONE
LANACORT
MICORT-HC
NEO-CORTEF
NSC-741
ORABASE HCA
|
|
12 |
|
Hydrocortisone |
Approved, Vet_approved |
Phase 4 |
|
50-23-7 |
3640 5754 |
Synonyms:
(11ALPHA,14BETA)-11,17,21-TRIHYDROXYPREGN-4-ENE-3,20-DIONE
(11b)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11Β)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(1S,2R,10S,11S,14S,15S,17S)-14,17-DIHYDROXY-14-(2-HYDROXYACETYL)-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
11 Epicortisol
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b,17a,21-Trihydroxy-4-pregnene-3,20-dione
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11-beta-Hydrocortisone
11beta-Hydroxycortisone
11-beta-Hydroxycortisone
11b-Hydrocortisone
11b-Hydroxycortisone
11-Epicortisol
11-Hydrocortisone
11Β,17α,21-trihydroxy-4-pregnene-3,20-dione
11Β-hydrocortisone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
17-Hydroxycorticosterone
4-Pregnen-11b,17a,21-triol-3,20-dione
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnen-11β,17α,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
ACETASOL HC
ACTICO МИХАИЛRT
Acticort
Acticort®|Efmody®|Plenadren®
Aeroseb HC
Aeroseb-HC
Alacort
Ala-cort
Ala-scalp
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort-HC
ANUGESIC HC
Anusol HC
ANUSOL PLUS HC
ANUSOL SOOTHING RELIEF
Anusol-HC
Aquacort
Aquanil HC
Balneol-HC
Barseb HC
Basan-corti
Beta-HC
b-HC
CaldeCORT spray
CALMURID HC
CANESTEN HC
Cetacort
Chronocort
CIPRO HC
Clear aid
Cleiton
Cobadex
Colocort
Compound F
CORLAN
Cor-oticin
Cortanal
Cor-tar-quin
Cort-dome
Cortef
CORTENEM
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisolonum
Cortisporin
Cortisporin otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cort-quin
CORTRIL
Cremesone
Cremicort-H
Cutisol
DAKTACORT
DAKTACORT HYDROCORT
Delacort
DERMA CARE HYDROCORT
Dermacort
Derm-aid
DERMASPRAY DEMANG
Dermil
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
ECONACORT
Ef corlin
Efcorbin
Efcortelan
EFCORTELAN P
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
EURAX-HC
EURAX-HYDROCORT
Evacort
EXE-CORT
Ficortril
Fiocortril
Flexicort
Foille insetti
Genacort
GERMOLOIDS HC
Glycort
GREGODERM
gyno-Cortisone
HC
|
HC #1
HC #4
HC (HYDROCORTISONE)
HC45
H-Cort
Heb cort
Heb-cort
Hi-cor
Hidalone
hidro-Colisona
Hidrocortisona
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
hydro-Adreson
hydro-Colisona
Hydrocort
HYDROCORT IN CALAMINE OILY
HYDROCORT IN CETOMACROGOL FOR A
HYDROCORT IN WTE SOFT PARAF
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone acetate
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone butyrate
Hydrocortisone free alcohol
Hydrocortisone in absorbase
Hydrocortisone sodium phosphate
Hydrocortisone valerate
Hydrocortisone, (11 alpha)-isomer
Hydrocortisone, (9 beta,10 alpha,11 alpha)-isomer
Hydrocortisonum
Hydrocortistab
Hydrocortisyl
HYDROCORTONE
HYDRODERM
HYDRODERM HC
hydro-RX
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone lotion
Idrocortisone
Incortin-H
Incortin-hydrogen
JUNGLE FOR
Kendall's compound F
Komed HC
Kyypakkaus
Lacticare HC
Lacticare-HC
Lactisona
Locoid
Lubricort
Maintasone
Medicort
Meusicort
Micort-HC
Mildison
MILDISON LIPOCREAM
Milliderm
neo-Cort-dome
neo-Cortef
Neosporin-H ear
Nogenic HC
NSC-10483
Nutracort
NYBADEX
Nystaform-HC
Ophthocort
Optef
Otalgine
Otic-neo-cort-dome
Otobiotic
Otocort
OTOSEPTIL
Otosone-F
OTOSPORIN
Pediotic suspension
Penecort
PERINAL
Permicort
Plenadren
Polcort H
Preparation H hydrocortisone cream
Prepcort
Prestwick_265
Prevex HC
Proctocort
PROCTOCREAM HC
Proctofoam
PROCTOFOAM HC
PROCTOSEDYL
Protocort
QUINOCORT
Racet
Rectoid
Reichstein's substance m
Remederm HC
Sanatison
Scalpicin capilar
Schericur
Scheroson F
SENTIAL HC
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral hydrocort
Tarcortin
Terra-cortril
TERRA-CORTRIL NYSTATIN
Texacort
Timocort
TIMODINE
Topicort
TOPISONE
Transderma H
Traumaide
TRI-CICATRIN
U-cort
Uniderm
UNIROID
UNIROID HC
Vioform-hydrocortisone
VoSol HC
Vytone
XYLOPROCT
Zenoxone
β-HC
|
|
13 |
|
Dabigatran |
Approved, Investigational |
Phase 4 |
|
211914-51-1 |
216210 |
Synonyms:
BIBR 1048
BIBR-953
BIBR-953-ZW
DABIGATRAN
Dabigatran etexilate
Dabigatran etexilate mesylate
|
Etexilate mesylate, dabigatran
Etexilate, dabigatran
Mesylate, dabigatran etexilate
N-((2-(((4-(Aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine
Pradaxa
|
|
14 |
|
Acetylsalicylic acid |
Approved, Vet_approved |
Phase 4 |
|
50-78-2 |
2244 |
Synonyms:
2-(ACETYLOXY)BENZOATE
2-(ACETYLOXY)benzoIC ACID
2-Acetoxybenzenecarboxylate
2-ACETOXYBENZENECARBOXYLIC ACID
2-ACETOXYBENZOATE
2-ACETOXYBENZOIC ACID
2-CARBOXYPHENYL ACETATE
8-HOUR BAYER
A.S.A.
A.S.A. Empirin
ACARD
ACENTERINE
Acesal
Acetal
ACETARD
ACETICYL
Acetilsalicilico
Acetilum acidulatum
Acetisal
ACETOL
ACETONYL
ACETOPHEN
Acetophen®|acetylsalicylic acid|Aspirin®
ACETOSAL
ACETOSALIC ACID
ACETOSALIN
Acetoxybenzoic acid
ACETYLIN
Acetylsal
ACETYLSALIC ACID
ACETYLSALICYLATE
ACETYLSALICYLIC ACID
Acetylsalicylsaeure
Acetylsalicylsaure
ACETYLSALICYLSÄURE
ACETYONYL
ACETYSAL
ACETYSALICYLIC ACID
Acid, acetylsalicylic
Acide 2-(acetyloxy)benzoique
ACIDE 2-(ACÉTYLOXY)BENZOÏQUE
Acide acetylsalicylique
ACIDE ACÉTYLSALICYLIQUE
Acido acetilsalicilico
ÁCIDO ACETILSALICÍLICO
Acido O-acetil-benzoico
ACIDUM ACETYLSALICYLICUM
Acimetten
Acisal
ACYLPYRIN
Adiro
ALKA RAPID
Aloxiprimum
ANADIN ALL NIGHT
ANGETTES 75
ASA
Asagran
ASATARD
Ascoden-30
Aspalon
Aspec
ASPERGUM
ASPIRDROPS
ASPIRIN
Aspirina
Aspirine
Aspro
ASPRO CLR
Asteric
Azetylsalizylsaeure
AZETYLSALIZYLSÄURE
BAY1019036
BAYER EXTRA STRENGTH
Bayer Extra Strength Aspirin For Migraine Pain
BENASPIR
Bialpirina
BIALPIRINIA
Bi-prin
BUFFERIN
CAPRIN
CARDIOASPIRINA
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
DANAMEP
Decaten
Delgesic
Dispril
DISPRIN CV
|
DISPRIN DIRECT
Dolean pH 8
Duramax
DURLAZA
EASPRIN
ECM
ECOLEN
ECOTRIN
EMPIRIN
ENDOSPRIN
ENDYDOL
ENPRIN
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
EQUI-PRIN
Extren
GENCARDIA
Globentyl
Globoid
Helicon
Idragin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LEVIUS
Magnecyl
MAX STRGH ASPRO CLR
MEASURIN
Micristin
MICROPIRIN EC
Neuronika
Novid
NSC-27223
NSC-406186
Nu-seals
NU-SEALS 300
NU-SEALS 600
NU-SEALS 75
Nu-seals aspirin
NU-SEALS CARDIO 75
O-(ACETYLOXY)BENZOATE
O-(ACETYLOXY)BENZOIC ACID
O-accetylsalicylic acid
O-ACETOXYBENZOATE
O-ACETOXYBENZOIC ACID
O-Acetylsalicylate
O-ACETYLSALICYLIC ACID
O-CARBOXYPHENYL ACETATE
O-Carboxyphenyl acetic acid
PAYNOCIL
PERSISTIN
PHARMACIN
Pirseal
PLATET
PLATET 300
Polopirin
POLOPIRYNA
POSTMI 300
POSTMI 75
PREMASPIN
RHEUMINTABLETTEN
RHODINE
Rhonal
Salacetin
SALCETOGEN
SALETIN
Salicylate acetate
SALICYLIC ACID ACETATE
Salicylic acid acetic acid
Salicylic acid, acetate
SALOSPIR
Solfrin
SOLPRIN
SOLPRIN ACID
SOLPYRON
Solupsan
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
TASPRIN
TEMPERAL
TOLDEX
TRIAMINICIN
Triple-sal
Vanquish
VAZALORE
Xaxa
Yasta
Zorprin
|
|
15 |
|
Ropivacaine |
Approved |
Phase 4 |
|
84057-95-4 |
71273 175805 |
Synonyms:
(-)-1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
(-)-1-Propyl-2',6'-pipecoloxylidide
(+-)-Ropivacaine
(S)-(-)-1-Propyl-2',6'-pipecoloxylidide
(S)-(−)-1-PROPYL-2',6'-PIPECOLOXYLIDIDE
(S)-ROPIVACAINE
1 Propyl 2',6' pipecoloxylidide
1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
1-Propyl-2',6'-pipecoloxylidide
1-propyl-2',6'-pipecoloxylidide|AL-381|LEA-103|Naropin®|ropivacaine hydrochloride
AL-381
DL-Ropivacaine
LEA 103
LEA-103
L-N-N-Propylpipecolate-2,6-xylidide
L-N-N-Propylpipecolic acid-2,6-xylidide
Naropeine
|
Naropin
N-N-Propylpipecolate-2,6-xylidide
N-N-Propylpipecolic acid-2,6-xylidide
Racemic ropivacaine
rac-Ropivacaine
Ropivacaina
Ropivacaina [INN-Spanish]
Ropivacaina [Spanish]
Ropivacaine
Ropivacaine [INN]
Ropivacaine hydrochloride
Ropivacaine monohydrochloride
Ropivacaine monohydrochloride, (S)-isomer
Ropivacainum
Ropivacainum [INN-Latin]
S-Ropivacaine
|
|
16 |
|
Dexmedetomidine |
Approved, Experimental, Vet_approved |
Phase 4 |
|
86347-14-0, 113775-47-6 |
68602 5311068 |
Synonyms:
(+)-4-((S)-a,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-Α,2,3-trimethylbenzyl)imidazole
(+-)-4-(a,2,3-Trimethylbenzyl)imidazole
(+-)-4-(alpha,2,3-Trimethylbenzyl)imidazole
(+-)-4-(Α,2,3-trimethylbenzyl)imidazole
(+)-MEDETOMIDINE
(±)-4-(α,2,3-trimethylbenzyl)imidazole
(S)-MEDETOMIDINE
Dexdor
Dexdor®|Igalmi® (dexmedetomidine sublingual film)|MPV 1440|Precedex®
DEXMEDETOMIDIN
Dexmedetomidina
DEXMEDETOMIDINE
DEXMÉDÉTOMIDINE
Dexmedetomidine hydrochloride
Dexmedetomidinum
|
Domitor
Hospira brand OF dexmedetomidine hydrochloride
Hydrochloride, dexmedetomidine
Hydrochloride, medetomidine
Levomedetomidine
Medetomidina
Medetomidina [Spanish]
Medetomidine
Medetomidine hydrochloride
Medetomidinum
Medetomidinum [Latin]
MPV 1440
MPV 785
MPV-1440
MPV-785
Precedex
|
|
17 |
|
Ketamine |
Approved, Vet_approved |
Phase 4 |
|
6740-88-1, 1867-66-9 |
3821 |
Synonyms:
(-)-Ketamine
(+-)-Ketamine
(±)-ketamine
(S)-(-)-Ketamine
(S)-Ketamine
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(O-Chlorophenyl)-2-(methylamino)-cyclohexanone
Calipsol
Calypsol
CI 581 base
CLSTA 20
DL-Ketamine
Esketamine
Kalipsol
Ketaject
Ketalar
|
Ketalar base
Ketalar|ketamine HCl
Ketamina
KETAMINE
Kétamine
Ketamine base
Ketamine HCL
Ketamine hydrochloride
Ketaminum
Ketanest
Ketaset
Ketolar
L-Ketamine
NMDA
NSC-70151
Special K
Tekam
|
|
18 |
|
Propofol |
Approved, Investigational, Vet_approved |
Phase 4 |
|
2078-54-8 |
4943 |
Synonyms:
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Diisopropylphenol
2,6-diisopropylphenol|Diprivan®|ICI 35868
Abbott brand OF propofol
Alpha Brand OF propofol
Aquafol
Astra brand OF propofol
AstraZeneca brand OF propofol
Braun brand OF propofol
Curamed brand OF propofol
Diisopropylphenol
Diprivan
Disoprivan
Disoprofol
Fresenius brand OF propofol
Fresenius kabi brand OF propofol
Fresofol
ICI 35868
ICI 35-868
|
ICI35,868
ICI-35868
Ivofol
Juste brand OF propofol
NSC-5105
Parnell brand OF propofol
Pisa brand OF propofol
Propofol
Propofol abbott
Propofol fresenius
Propofol MCT
Propofol rovi
Propofol-lipuro
Propofolum
Rapinovet
Recofol
Rovi brand OF propofol
Schering brand OF propofol
Zeneca brand OF propofol
|
|
19 |
|
Magnesium sulfate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
7487-88-9 |
|
Synonyms:
Magnesium sulfate (1:1)
Magnesium sulfate anhydrous
Magnesium sulphate
|
magnesium(II) sulfate
Magnesiumsulfat
MgSO4
|
|
20 |
|
Midazolam |
Approved, Illicit |
Phase 4 |
|
59467-70-8 |
4192 |
Synonyms:
Buccolam
Buccolam®|Dormicum®|Nayzilam®|USL261 (nasal spray formulation)|Versed®
Dea no. 2884
Dormicum
Hydrochloride, midazolam
Maleate, midazolam
Mezolam
Midazolam
Midazolam base
MIDAZOLAM CIV
|
Midazolam Hcl
Midazolam hydrochloride
Midazolam maleate
Midazolamum
Midazolamum [INN-Latin]
Nayzilam
USL261
USL-261
Versed
|
|
21 |
|
Morphine |
Approved, Investigational |
Phase 4 |
|
57-27-2 |
5288826 |
Synonyms:
(-)-Heroin hydrochloride
(-)-Morphine
(−)-MORPHINE
(5a,6a)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5a,6a)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol
(5Α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5Α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(7R,7AS,12BS)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
ANHYDROUS MORPHINE
Apokyn
Astramorph PF
AVINZA
Chloride, morphine
Contin, MS
D-(-)-Morphine
DEPODUR
Diacetylmorphine hydrochloride
Diamorphine hydrochloride
Dulcontin
Duramorph
Duramorph PF
Duromorph
Epimorph
Heroin hydrochloride
Heroine hydrochloride
IDS-NM-009
INFUMORPH
KADIAN
l-Morphine
M.O.S
Meconium
M-Eslon
Morfina
Morfina dosa
|
Morphia
Morphin
Morphina
MORPHINE
Morphine chloride
Morphine Extra-Forte
Morphine Forte
Morphine H.P
Morphine sulfate
Morphine sulfate (2:1), anhydrous
Morphine sulfate (2:1), pentahydrate
morphine sulfate|Ms Contin®|Oramorph®
Morphinism
Morphinum
Morphitec
Morphium
Moscontin
MS Contin
MS/L
MS/S
MSIR
N02AA01
Nepenthe
O,O'-Diacetylmorphine hydrochloride
OMS Concentrate
ORAMORPH
Oramorph SR
Ospalivina
Rescudose
RMS Uniserts
Roxanol
Roxanol 100
Roxanol UD
Statex
Statex Drops
Substitol
Sulfate, morphine
|
|
22 |
|
Isoflurane |
Approved, Vet_approved |
Phase 4 |
|
26675-46-7 |
3763 |
Synonyms:
1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether
Aerrane
COMPOUND 469
COMPOUND-469
Ethane
Forane
Forane®
|
Forene
HCFE-235DA2
Isoflurane
Isoflurane [Usan:Ban:Inn:Jan]
Isoflurano
Isofluranum
Isofluranum [INN-Latin]
|
|
23 |
|
Atracurium |
Approved, Experimental, Investigational |
Phase 4 |
|
64228-79-1 |
47319 |
Synonyms:
1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium
ATRACURIUM
Atracurium besilate
atracurium besilate|atracurium dibesylate|BW 33A|Tracrium®
Atracurium besylate
Atracurium dibesylate
Besilate, atracurium
BW 33a
|
BW33a
BW-33a
Glaxo wellcome brand OF atracurium besilate
Pisa brand OF atracurium besilate
Relatrac
Tracrium
Wellcome brand OF atracurium besilate
|
|
24 |
|
Rocuronium |
Approved |
Phase 4 |
|
119302-91-9, 143558-00-3 |
441290 |
Synonyms:
1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
Esmeron
Esmerone
ORG-9426
Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
|
Rocuronio
ROCURONIUM
Rocuronium bromide
Zemuron
|
|
25 |
|
Vecuronium |
Approved, Investigational |
Phase 4 |
|
50700-72-6, 86029-43-8 |
39765 39764 |
Synonyms:
1-(3ALPHA,17BETA-DIHYDROXY-2BETA-PIPERIDINO-5ALPHA-ANDROSTAN-16BETA,5ALPHA-YL)-1-METHYLPIPERIDINIUM BROMIDE, DIACETATE
1-[3ALPHA,17BETA-BIS(ACETOXY)-2BETA-(1-PIPERIDINYL)-5ALPHA-ANDROSTAN-16BETA-YL]-1-METHYLPIPERIDINIUM BROMIDE
Bromide, vecuronium
Citrate, vecuronium
Hydrobromide, vecuronium
Hydrochloride, vecuronium
Maleate, vecuronium
MUSCULAX
NC 45
NC-45
Norcuron
ORG NC 45
ORG NC 45 / ORG-NC 45
ORG NC45
ORGNC 45
|
ORG-NC 45
ORGNC45
ORG-NC45
ORG-NC-45
Phosphate, vecuronium
Vecuronio
VECURONIUM
Vecuronium bromide
Vecuronium bromide, quaternary ion
Vecuronium cation
Vecuronium citrate
Vecuronium hydrobromide
Vecuronium hydrochloride
Vecuronium maleate
Vecuronium phosphate
|
|
26 |
|
Carbetocin |
Approved, Investigational |
Phase 4 |
|
37025-55-1 |
16681432 |
Synonyms:
1-Butanoate-2-(O-methyl-L-tyrosine)-1-carbaoxytocin
1-Butanoic acid-2-(O-methyl-L-tyrosine)-1-carbaoxytocin
1-Butyrate-2-(3-(p-methoxyphenyl)-L-alanine)oxytocin
1-Butyric acid-2-(3-(p-methoxyphenyl)-L-alanine)oxytocin
1-Deamino-1-monocarba-2-(tyr(ome))-oxytocin
CARBETOCIN
Carbetocina
Carbetocino
|
Carbetocinum
Dcomot
Deamino-2-O-methyltyrosine-1-carbaoxytocin
Depotocin
LV-101
PABAL
Pabal®
|
|
27 |
|
Oxytocin |
Approved, Vet_approved |
Phase 4 |
|
50-56-6 |
439302 53477758 |
Synonyms:
(2S)-2-[({1-[(4R,7S,10S,13S,16S,19R)-19-amino-13-[(2S)-butan-2-yl]-6,9,12,15,18-pentahydroxy-10-[2-(C-hydroxycarbonimidoyl)ethyl]-7-[(C-hydroxycarbonimidoyl)methyl]-16-[(4-hydroxyphenyl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carbonyl]pyrrolidin-2-yl}(hydroxy)methylidene)amino]-N-[(C-hydroxycarbonimidoyl)methyl]-4-methylpentanimidate
(Arg8)-vasopressin
(Arg8)-vasotocin
[<sup>3</sup>H]oxytocin
alpha-Hypophamine
Argipressin
Argpressin acetate
Biotinyl-(arg8)-vasopressin
Cys-tyr-ile-GLN-asn-cys-pro-arg-gly-NH2
Cys-tyr-ile-GLN-asn-cys-pro-leu-gly-NH2
Cys-tyr-ile-THR-asn-cys-gly-leu-gly-NH2
Cys-tyr-phe-GLN-asn-cys-pro-arg-gly-NH2
Cys-tyr-phe-GLN-asn-cys-pro-lys-gly-NH2
Disulfide bridge cys1-cys6
Gly-leu-pro-c
Ocytocin
|
ORASTHIN
Oxitocina
OXT
OXYTOCIN
Oxytocin 10 usp units in dextrose 5%
Oxytocin 20 usp units in dextrose 5%
Oxytocin 5 usp units in dextrose 5%
Oxytocin acetate
Oxytocin injection
PITOCIN
SID29217903
SID50111741
SYNTOCINON
SYNTOMETRINE
SYT670
TTA-121
|
|
28 |
|
Cysteine |
Approved, Nutraceutical |
Phase 4 |
|
52-90-4 |
594 5862 |
Synonyms:
(+)-2-AMINO-3-MERCAPTOPROPIONIC ACID
(2R)-2-AMINO-3-MERCAPTOPROPANOATE
(2R)-2-AMINO-3-MERCAPTOPROPANOIC ACID
(2R)-2-AMINO-3-MERCAPTO-PROPANOIC ACID
(2R)-2-AMINO-3-SULFANYLPROPANOATE
(2R)-2-AMINO-3-SULFANYLPROPANOIC ACID
(2R)-2-AMINO-3-SULFANYL-PROPANOIC ACID
(2R)-2-Amino-3-sulphanylpropanoate
(2R)-2-Amino-3-sulphanylpropanoic acid
(R)-(+)-CYSTEINE
(R)-2-AMINO-3-MERCAPTOPROPANOATE
(R)-2-AMINO-3-MERCAPTO-PROPANOATE
(R)-2-AMINO-3-MERCAPTOPROPANOIC ACID
(R)-2-AMINO-3-MERCAPTO-PROPANOIC ACID
(R)-CYSTEINE
2-Amino-3-mercaptopropanoate
2-Amino-3-mercaptopropanoic acid
2-Amino-3-mercaptopropionate
2-Amino-3-mercaptopropionic acid
2-Amino-3-sulfanylpropanoate
2-Amino-3-sulfanylpropanoic acid
2-Amino-3-sulphanylpropanoate
2-Amino-3-sulphanylpropanoic acid
3-MERCAPTO-L-ALANINE
ACETYLCYSTEINE
ALPHA-AMINO-BETA-THIOLPROPIONIC ACID
BETA-MERCAPTOALANINE
B-MERCAPTOALANINE
C
CARBOCYSTEINE
Cisteina
|
CISTEINUM
Cys
Cystein
Cysteine
CYSTEINE HCL
Cysteine hydrochloride
CYSTEINUM
E 920
E920
E-920
E921
Ecolan
FREE CYSTEINE
Half cystine
Half-cystine
Hcys
L Cysteine
L-(+)-CYSTEINE
L-2-AMINO-3-MERCAPTOPROPANOATE
L-2-AMINO-3-MERCAPTOPROPANOIC ACID
L-2-Amino-3-mercaptopropionate
L-2-AMINO-3-MERCAPTOPROPIONIC ACID
L-CYS
L-CYSTEIN
L-Cysteine
L-ZYSTEIN
POLYCYSTEINE
THIOSERINE
Zinc cysteinate
Zystein
|
|
29 |
|
Thiamine |
Approved, Investigational, Nutraceutical, Vet_approved |
Phase 4 |
|
70-16-6 |
1130 |
Synonyms:
[<sup>3</sup>H]-thiamine|[<sup>3</sup>H]vitamin B<sub>1</sub>
2-[3-[(4-AMINO-2-METHYL-PYRIMIDIN-5-YL)METHYL]-4-METHYL-1-THIA-3-AZONIACYCLOPENTA-2,4-DIEN-5-YL]ETHANOL
2-[3-[(4-AMINO-2-METHYL-PYRIMIDIN-5-YL)METHYL]-4-METHYL-THIAZOL-5-YL]ETHANOL
3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM
ANEURIN
ANTIBERIBERI FACTOR
APATE DROPS
BEATINE
BEDOME
BEGIOLAN
BENERVA
BEQUIN
BERIN
BETALIN S
BETAXIN
BETHIAZINE
BEUION
BEVITEX
BEVITINE
BEWON
BIAMINE
BITHIAMIN
BIUNO
BIVATIN
BIVITA
CERNEVIT-12
CLOTIAMINA
ESKAPEN
|
ESKAPHEN
HYBEE
LIXA-BETA
METABOLIN
Mononitrate, thiamine
SLOWTEN
THD
THIADOXINE
THIAMIN
THIAMINAL
THIAMINE
Thiamine mononitrate
THIAMINE(1+)
THIAMINE(1+) ION
THIAMINIUM
Thiaminum
THIAMOL
THIAVIT
TIAMIDON
TIAMINA
TIAMINAL
TROPHITE
VETALIN S
VIB
VINOTHIAM
VITAMIN B 1
VITAMIN B1
VITANEURON
|
|
30 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
31 |
|
Simendan |
Investigational |
Phase 4 |
|
131741-08-7 |
|
Synonyms:
((4-(1,4,5,6-tetrahydro-4-Methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile
Dextrosimendan
Levosimendan
|
|
|
32 |
|
Antioxidants |
|
Phase 4 |
|
|
|
33 |
|
Protective Agents |
|
Phase 4 |
|
|
|
34 |
|
Chrysarobin |
|
Phase 4 |
|
|
|
35 |
|
Antiviral Agents |
|
Phase 4 |
|
|
|
36 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
37 |
|
Expectorants |
|
Phase 4 |
|
|
|
38 |
|
Antidotes |
|
Phase 4 |
|
|
|
39 |
|
N-monoacetylcystine |
|
Phase 4 |
|
|
|
40 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
41 |
|
Adrenergic beta-Antagonists |
|
Phase 4 |
|
|
|
42 |
|
Adrenergic beta-1 Receptor Antagonists |
|
Phase 4 |
|
|
|
43 |
|
Adrenergic Antagonists |
|
Phase 4 |
|
|
|
44 |
|
Sympatholytics |
|
Phase 4 |
|
|
|
45 |
|
Platelet Aggregation Inhibitors |
|
Phase 4 |
|
|
|
46 |
|
Phosphodiesterase Inhibitors |
|
Phase 4 |
|
|
|
47 |
|
Vitamin B1 |
|
Phase 4 |
|
|
|
48 |
|
Phosphodiesterase 3 Inhibitors |
|
Phase 4 |
|
|
|
49 |
|
Thiamin |
|
Phase 4 |
|
|
|
50 |
|
Dsuvia |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 365)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Frailty and Cognitive Function Assessment of TAVI Patients (The Hungarian Frailty Score) - Observational, Prospective, Singe Center Study |
Unknown status |
NCT02650388 |
Phase 4 |
|
2 |
The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement. |
Unknown status |
NCT02710747 |
Phase 4 |
|
3 |
Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients |
Unknown status |
NCT01610141 |
Phase 4 |
|
4 |
Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement |
Unknown status |
NCT03440268 |
Phase 4 |
N Acetyl Cysteine;Placebos |
5 |
Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Out-patients Undergoing Diagnostic Trans-esophageal Echocardiography: A Randomized Controlled Trial |
Completed |
NCT02867930 |
Phase 4 |
Dexmedetomidine;Ketofol(ketamine+propofol) |
6 |
The Effects of Levosimendan on Haemodynamics in Patients Undergoing Elective Aortic Valve Replacement (AVR)Together With Coronary Artery Bypass Grafting |
Completed |
NCT01210976 |
Phase 4 |
levosimendan;placebo |
7 |
Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery: A Prospective, Randomized Controlled Trial |
Completed |
NCT01384643 |
Phase 4 |
Propofol |
8 |
Sildenafil for Improving Outcomes After Valvular Correction |
Completed |
NCT00862043 |
Phase 4 |
Sildenafil Citrate;Placebo |
9 |
Effect of Propofol and Sevoflurane on Serum CD39 and CD73 Level After Open Heart Surgery With Cardiopulmonary Bypass |
Completed |
NCT02136979 |
Phase 4 |
Propofol;Sevoflurane |
10 |
Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery |
Completed |
NCT03280745 |
Phase 4 |
Hypertonic saline;0.9% saline |
11 |
The Changes in Cortisol Levels and Stress Responses During Cardiac Surgery. The Comparison Between Two Induction Agents: Etomidate and Thiopentone. |
Completed |
NCT01495949 |
Phase 4 |
etomidate;thiopentone |
12 |
The Effect of Propofol on Tissue Doppler Imaging of Mitral Valve Annular Velocity During Remifentanil-based Cardiac Anesthesia |
Completed |
NCT01826149 |
Phase 4 |
Propofol 1.0mcg;Propofol 2.0mcg;Propofol 3.0mcg |
13 |
Phase 4 Study Comparing Albumin 5%, Hydroxyethylstrach 130/0.4 (6%) and Ringer Lactate for Volume Replacement During Cardiac Surgery |
Completed |
NCT01174719 |
Phase 4 |
volume replacement;Humanalbumin 5% |
14 |
Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery: A Prospective Randomized Clinical Trial. |
Completed |
NCT01477151 |
Phase 4 |
Volatile anesthetic |
15 |
The Ontario Multidetector Computed Tomography (MDCT) Coronary Angiography Study (OMCAS) |
Completed |
NCT00371891 |
Phase 4 |
|
16 |
Beta Blockade in Mitral Regurgitation |
Completed |
NCT00166400 |
Phase 4 |
metoprolol succinate |
17 |
Effect of Combined Remote Ischemic Preconditioning and Postconditioning on Acute Pulmonary Injury in Patients Undergoing Valvular Heart Surgery |
Completed |
NCT01427621 |
Phase 4 |
|
18 |
Effectiveness of Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Aortic and Mitral Valvular Atrial Fibrillation Patients |
Completed |
NCT02982850 |
Phase 4 |
Dabigatran;Acetylsalicylic acid;Warfarin |
19 |
Ultrasound Guided Repeated Bilateral Transversus Thoracis Muscle Plane Block Via Catheter and Postoperative Pain in Cardiac Surgery |
Recruiting |
NCT04916418 |
Phase 4 |
Placebo;Ropivacaine |
20 |
Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis , in Patients Undergoing Cardiovascular Surgery: Randomized Clinical Trial |
Recruiting |
NCT05079672 |
Phase 4 |
Dexmedetomidine;0,9% Saline |
21 |
Different Modalities of Analgesia in Open Heart Surgeries in Mansoura University: Randomized Prospective Comparative Study |
Active, not recruiting |
NCT04223219 |
Phase 4 |
Fentanyl;Fentanyl, Propofol;Dexmedetomidine, Ketamine, Magnesium sulfate |
22 |
Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients With Stenotic Valvular Heart Disease Undergoing Caesarean Section |
Not yet recruiting |
NCT05110482 |
Phase 4 |
Syntocinon;Carbetocin |
23 |
Sugammadex Titration for Reversal of Rocuronium or Vecuronium in Cardiac Surgery Patients |
Not yet recruiting |
NCT05246397 |
Phase 4 |
Sugammadex administration |
24 |
Anticoagulation Treatment Influence on Post-operative Patients -Action SJM EPIC Trial |
Withdrawn |
NCT00187304 |
Phase 4 |
|
25 |
Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications |
Unknown status |
NCT01000233 |
Phase 2, Phase 3 |
|
26 |
"Salvage Use" of Recombinant Activated Factor VII After Inadequate Haemostatic Response to Conventional Therapy in Complex Cardiac Surgery - a Randomised Placebo Controlled Trial |
Unknown status |
NCT00214656 |
Phase 3 |
Recombinant Activated Factor VII |
27 |
Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair |
Completed |
NCT02084069 |
Phase 3 |
Atorvastatin |
28 |
Risk Reduction of Symptomatic and Silent Brain Infarctions During Cardiac Surgery Due to Ultrasound Activation of Endogenous Fibrinolytic System Using Transcranial Doppler Monitoring |
Completed |
NCT01591018 |
Phase 3 |
|
29 |
Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery |
Completed |
NCT05223361 |
Phase 3 |
Six percent hydroxy ethyl starch 130/0.4;Ringer lactate |
30 |
Randomized Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT) - Substudy of the GALILEO-trial |
Completed |
NCT02833948 |
Phase 3 |
Acetylsalicylic acid;Clopidogrel;Rivaroxaban |
31 |
Perioperative Infusion of Dexmedetomidine Improves Outcomes of Cardiovascular Surgery |
Completed |
NCT02237495 |
Phase 2, Phase 3 |
dexmedetomidine;placebo |
32 |
Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve (BICATOR) |
Completed |
NCT02679261 |
Phase 3 |
Atorvastatin;Placebo |
33 |
An Adaptive Phase 2/3 Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel, 3 Arm Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS) |
Recruiting |
NCT05143177 |
Phase 2, Phase 3 |
Evogliptin;Placebo |
34 |
The Safety and Effectiveness of the SAPIEN 3 and SAPIEN 3 Ultra Valve in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification Who Are Not Candidates for Standard Mitral Valve Surgery. |
Recruiting |
NCT04408430 |
Phase 2, Phase 3 |
|
35 |
Magnesium for the Prevention of Atrial Arrhythmias After Cardiac Surgery |
Terminated |
NCT00250965 |
Phase 3 |
intravenous magnesium |
36 |
Clinical Trial Comparing a Conventional Median Sternotomy Versus a Minimally Invasive Technique for Aortic Valvular Replacement in Adults |
Terminated |
NCT00221663 |
Phase 2, Phase 3 |
|
37 |
Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis |
Terminated |
NCT03566303 |
Phase 2, Phase 3 |
Rivaroxaban 15 mg;Warfarin |
38 |
Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II (the PRINT II Study): a Randomized Controlled, Non-inferiority Trial Comparing 4-weekly With 12-weekly Testing and Dose-assessment |
Withdrawn |
NCT01654042 |
Phase 3 |
|
39 |
Cardiac Operation Under Totally Endoscope and Cardiopulmonary Bypass, a Single Center's Experience |
Unknown status |
NCT00921596 |
Phase 1, Phase 2 |
|
40 |
Bicuspid Aortic Valve Stenosis and the Effect of vItamin K2 on Calciummetabolism on 18F-NaF PET/MRI (BASIK2): a Pilot Study |
Unknown status |
NCT02917525 |
Phase 2 |
|
41 |
A Prospective, Randomized, Multicenter Clinical Study on the High Vacuum Body Cavity Drainage Systems Following Open Heart Surgery |
Completed |
NCT00581399 |
Phase 2 |
|
42 |
Phase II Study of Double Versus Single Reinitiation Dose of Warfarin After Interruption for Surgery |
Completed |
NCT01348074 |
Phase 2 |
Double dose |
43 |
CopenHeartVR - A Randomized Clinical Trial Investigating the Effect of Integrated Rehabilitation Versus Usual Care Without Physical Exercise After Heart Valve Surgery. |
Completed |
NCT01558765 |
Phase 2 |
|
44 |
A Phase 2, Randomized, Open Label, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Rivaroxaban Compared With Vitamin K Antagonism in Patients With Atrial Fibrillation With Bioprosthetic Mitral Valves - RIVER |
Completed |
NCT02303795 |
Phase 2 |
Rivaroxaban;Warfarin |
45 |
Custodiol-HTK Solution as a Cardioplegic Agent- A Prospective Non-Inferiority Randomized Clinical Trial |
Completed |
NCT01681095 |
Phase 2 |
Custodiol HTK;Cold Blood Cardioplegia |
46 |
N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement. |
Completed |
NCT01704482 |
Phase 2 |
N-acetylcysteine;placebo |
47 |
The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS) Applied on Cardiac Surgery With Cardiopulmonary Bypass: a Single Center, Randomized, Controlled Clinical Study |
Completed |
NCT02479581 |
Phase 2 |
|
48 |
Cytokine Clearance With Cytoabsorbant Device During Cardiac Bypass: a Pilot Study |
Completed |
NCT02775123 |
Phase 1, Phase 2 |
|
49 |
Nitric Oxide Supplementation to the Extracorporeal Circulation Line as a Method of Nephroprotection in Cardiac Surgery |
Completed |
NCT03527381 |
Phase 1, Phase 2 |
Nitric Oxide |
50 |
A Randomized Double-blind Study of 4-weekly Versus 12-weekly Monitoring of Stable Patients on Long-term Anticoagulation With Warfarin |
Completed |
NCT00356759 |
Phase 2 |
Dosing warfarin every 12 weeks, sham INRs 2 out of 3 times |
|